1,252 research outputs found
Entanglement without nonlocality
We consider the characterization of entanglement from the perspective of a
Heisenberg formalism. We derive an original two-party generalized separability
criteria, and from this describe a novel physical understanding of
entanglement. We find that entanglement may be considered as fundamentally a
local effect, and therefore as a separable computational resource from
nonlocality. We show how entanglement differs from correlation physically, and
explore the implications of this new conception of entanglement for the notion
of classicality. We find that this understanding of entanglement extends
naturally to multipartite cases.Comment: 9 pages. Expanded introduction and sections on physical entanglement
and localit
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
Objectives: To assess the associations between both uric acid levels and hyperuricaemia, with ischaemic heart disease and blood pressure, and to explore the potentially confounding role of body mass index.
Design: Mendelian randomisation analysis, using variation at specific genes (SLC2A9 (rs7442295) as an instrument for uric acid; and FTO (rs9939609), MC4R (rs17782313), and TMEM18 (rs6548238) for body mass index).
Setting: Two large, prospective cohort studies in Denmark.
Participants: We measured levels of uric acid and related covariables in 58 072 participants from the Copenhagen General Population Study and 10 602 from the Copenhagen City Heart Study, comprising 4890 and 2282 cases of ischaemic heart disease, respectively.
Main outcome: Blood pressure and prospectively assessed ischaemic heart disease.
Results: Estimates confirmed known observational associations between plasma uric acid and hyperuricaemia with risk of ischaemic heart disease and diastolic and systolic blood pressure. However, when using genotypic instruments for uric acid and hyperuricaemia, we saw no evidence for causal associations between uric acid, ischaemic heart disease, and blood pressure. We used genetic instruments to investigate body mass index as a potentially confounding factor in observational associations, and saw a causal effect on uric acid levels. Every four unit increase of body mass index saw a rise in uric acid of 0.03 mmol/L (95% confidence interval 0.02 to 0.04), and an increase in risk of hyperuricaemia of 7.5% (3.9% to 11.1%).
Conclusion: By contrast with observational findings, there is no strong evidence for causal associations between uric acid and ischaemic heart disease or blood pressure. However, evidence supports a causal effect between body mass index and uric acid level and hyperuricaemia. This finding strongly suggests body mass index as a confounder in observational associations, and suggests a role for elevated body mass index or obesity in the development of uric acid related conditions
Einstein-Podolsky-Rosen correlations of Dirac particles - quantum field theory approach
We calculate correlation function in the Einstein--Podolsky--Rosen type of
experiment with massive relativistic Dirac particles in the framework of the
quantum field theory formalism. We perform our calculations for states which
are physically interesting and transforms covariantly under the full Lorentz
group action, i.e. for pseudoscalar and vector state.Comment: 9 pages, 2 figures. Published versio
Formulation of the uncertainty relations in terms of the Renyi entropies
Quantum mechanical uncertainty relations for position and momentum are
expressed in the form of inequalities involving the Renyi entropies. The proof
of these inequalities requires the use of the exact expression for the
(p,q)-norm of the Fourier transformation derived by Babenko and Beckner.
Analogous uncertainty relations are derived for angle and angular momentum and
also for a pair of complementary observables in N-level systems. All these
uncertainty relations become more attractive when expressed in terms of the
symmetrized Renyi entropies
Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.
Finding individual-level data for adequately-powered Mendelian randomization analyses may be problematic. As publicly-available summarized data on genetic associations with disease outcomes from large consortia are becoming more abundant, use of published data is an attractive analysis strategy for obtaining precise estimates of the causal effects of risk factors on outcomes. We detail the necessary steps for conducting Mendelian randomization investigations using published data, and present novel statistical methods for combining data on the associations of multiple (correlated or uncorrelated) genetic variants with the risk factor and outcome into a single causal effect estimate. A two-sample analysis strategy may be employed, in which evidence on the gene-risk factor and gene-outcome associations are taken from different data sources. These approaches allow the efficient identification of risk factors that are suitable targets for clinical intervention from published data, although the ability to assess the assumptions necessary for causal inference is diminished. Methods and guidance are illustrated using the example of the causal effect of serum calcium levels on fasting glucose concentrations. The estimated causal effect of a 1 standard deviation (0.13 mmol/L) increase in calcium levels on fasting glucose (mM) using a single lead variant from the CASR gene region is 0.044 (95 % credible interval -0.002, 0.100). In contrast, using our method to account for the correlation between variants, the corresponding estimate using 17 genetic variants is 0.022 (95 % credible interval 0.009, 0.035), a more clearly positive causal effect.We thank all EPIC participants and staff for their contribution to the study. We thank staff from the Technical, Field Epidemiology and Data Functional Group Teams of the MRC Epidemiology Unit in Cambridge, UK, for carrying out sample preparation, DNA provision and quality control, genotyping and data-handling work. Funding for the biomarker measurements in the random subcohort was provided by grants to EPIC-InterAct from the European Community Framework Programme 6 (Integrated Project LSHM-CT-2006-037197) and to EPIC-Heart from the Medical Research Council and British Heart Foundation (Joint Award G0800270). Stephen Burgess is supported by the Wellcome Trust (Grant Number 100114). Simon G. Thompson is supported by the British Heart Foundation (Grant Number CH/12/2/29428). No specific funding was received for the writing of this manuscript.This is the final version of the article. It first appeared from Springer via http://dx.doi.org/10.1007/s10654-015-0011-
Assumption-free estimation of the genetic contribution to refractive error across childhood
Purpose: Studies in relatives have generally yielded high heritability estimates for refractive error: twins 75–90%, families 15–70%. However, because related individuals often share a common environment, these estimates are inflated (via misallocation of unique/common environment variance). We calculated a lower-bound heritability estimate for refractive error free from such bias. Methods: Between the ages 7 and 15 years, participants in the Avon Longitudinal Study of Parents and Children (ALSPAC) underwent non-cycloplegic autorefraction at regular research clinics. At each age, an estimate of the variance in refractive error explained by single nucleotide polymorphism (SNP) genetic variants was calculated using genome-wide complex trait analysis (GCTA) using high-density genome-wide SNP genotype information (minimum N at each age=3,404). Results: The variance in refractive error explained by the SNPs (“SNP heritability”) was stable over childhood: Across age 7–15 years, SNP heritability averaged 0.28 (SE=0.08,
A toy model for quantum mechanics
The toy model used by Spekkens [R. Spekkens, Phys. Rev. A 75, 032110 (2007)]
to argue in favor of an epistemic view of quantum mechanics is extended by
generalizing his definition of pure states (i.e. states of maximal knowledge)
and by associating measurements with all pure states. The new toy model does
not allow signaling but, in contrast to the Spekkens model, does violate
Bell-CHSH inequalities. Negative probabilities are found to arise naturally
within the model, and can be used to explain the Bell-CHSH inequality
violations.Comment: in which the author breaks his vow to never use the words "ontic" and
"epistemic" in publi
A multivariant recall-by-genotype study of the metabolomic signature of BMI
OBJECTIVE: This study estimated the effect of BMI on circulating metabolites in young adults using a recall‐by‐genotype study design. METHODS: A recall‐by‐genotype study was implemented in the Avon Longitudinal Study of Parents and Children. Samples from 756 participants were selected for untargeted metabolomics analysis based on low versus high genetic liability for higher BMI defined by a genetic risk score (GRS). Regression analyses were performed to investigate associations between BMI GRS group and relative abundance of 973 metabolites. RESULTS: After correction for multiple testing, 29 metabolites were associated with BMI GRS group. Bilirubin was among the most strongly associated metabolites, with reduced levels measured in individuals in the high‐BMI GRS group (β = −0.32, 95% CI: −0.46 to −0.18, Benjamini‐Hochberg adjusted p = 0.005). This study observed associations between BMI GRS group and the levels of several potentially diet‐related metabolites, including hippurate, which had lower mean abundance in individuals in the high‐BMI GRS group (β = −0.29, 95% CI: −0.44 to −0.15, Benjamini‐Hochberg adjusted p = 0.008). CONCLUSIONS: Together with existing literature, these results suggest that a genetic predisposition to higher BMI captures differences in metabolism leading to adiposity gain. In the absence of prospective data, separating these effects from the downstream consequences of weight gain is challenging
Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid
Background: Observational studies showed that circulating l-ascorbic acid (vitamin C) is inversely associated with cardiometabolic traits. However, these studies were susceptible to confounding and reverse causation.
Objectives:We assessed the relation between l-ascorbic acid and 10 cardiometabolic traits by using a single nucleotide polymorphism in the solute carrier family 23 member 1 (SLC23A1) gene (rs33972313) associated with circulating l-ascorbic acid concentrations. The observed association between rs33972313 and cardiometabolic outcomes was compared with that expected given the rs33972313-l-ascorbic acid and l-ascorbic acid–outcome associations.
Design: A meta-analysis was performed in the following 5 independent studies: the British Women's Heart and Health Study (n = 1833), the MIDSPAN study (n = 1138), the Ten Towns study (n = 1324), the British Regional Heart Study (n = 2521), and the European Prospective Investigation into Cancer (n = 3737).
Results: With the use of a meta-analysis of observational estimates, inverse associations were shown between l-ascorbic acid and systolic blood pressure, triglycerides, and the waist-hip ratio [the strongest of which was the waist-hip ratio (−0.13-SD change; 95% CI: −0.20-, −0.07-SD change; P = 0.0001) per SD increase in l-ascorbic acid], and a positive association was shown with high-density lipoprotein (HDL) cholesterol. The variation at rs33972313 was associated with a 0.18-SD (95% CI: 0.10-, 0.25-SD; P = 3.34 × 10−6) increase in l-ascorbic acid per effect allele. There was no evidence of a relation between the variation at rs33972313 and any cardiometabolic outcome. Although observed estimates were not statistically different from expected associations between rs33972313 and cardiometabolic outcomes, estimates for low-density lipoprotein cholesterol, HDL cholesterol, triglycerides, glucose, and body mass index were in the opposite direction to those expected.
Conclusions: The nature of the genetic association exploited in this study led to limited statistical application, but despite this, when all cardiometabolic traits were assessed, there was no evidence of any trend supporting a protective role of l-ascorbic acid. In the context of existing work, these results add to the suggestion that observational relations between l-ascorbic acid and cardiometabolic health may be attributable to confounding and reverse causation
- …